Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    7308988 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
2 Completed Development of a Breath Test for Monitoring Patients With Liver Disease
Conditions: Fatty Liver;   Cirrhosis
Interventions: Drug: 13C-Methacetin;   Device: Breath ID Machine
3 Completed Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen
Conditions: Chronic Hepatitis C;   Organ Transplantation;   Immunosuppression
Interventions: Drug: Neoral;   Drug: Tacrolimus
To Top

† Indicates status has not been verified in more than two years